| Literature DB >> 27097323 |
Guillaume Marzolf1, Marcela Sabou2, Béatrice Lannes3, François Cotton4, David Meyronet5, Damien Galanaud6, Jean-Philippe Cottier7, Sylvie Grand8, Hubert Desal9, Julie Kreutz10, Maleka Schenck11, Nicolas Meyer12, Francis Schneider11, Jean-Louis Dietemann1, Meriam Koob1, Raoul Herbrecht13, Stéphane Kremer1.
Abstract
Cerebral aspergillosis is associated with a significant morbidity and mortality rate. The imaging data present different patterns and no full consensus exists on typical imaging characteristics of the cerebral lesions. We reviewed MRI findings in 21 patients with cerebral aspergillosis and correlated them to the immune status of the patients and to neuropathological findings when tissue was available. The lesions were characterized by their number, topography, and MRI signal. Dissemination to the brain resulted from direct spread from paranasal sinuses in 8 patients, 6 of them being immunocompetent. Hematogenous dissemination was observed in 13 patients, all were immunosuppressed. In this later group we identified a total of 329 parenchymal abscesses involving the whole brain with a predilection for the corticomedullary junction. More than half the patients had a corpus callosum lesion. Hemorrhagic lesions accounted for 13% and contrast enhancement was observed in 61% of the lesions. Patients with hematogenous dissemination were younger (p = 0.003), had more intracranial lesions (p = 0.0004) and had a higher 12-week mortality rate (p = 0.046) than patients with direct spread from paranasal sinuses. Analysis of 12 aneurysms allowed us to highlight two distinct situations. In case of direct spread from the paranasal sinuses, aneurysms are saccular and located on the proximal artery portions, while the hematogenous dissemination in immunocompromised patients is more frequently associated with distal and fusiform aneurysms. MRI is the exam of choice for cerebral aspergillosis. Number and type of lesions are different according to the mode of dissemination of the infection.Entities:
Mesh:
Year: 2016 PMID: 27097323 PMCID: PMC4838310 DOI: 10.1371/journal.pone.0152475
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Review of comparable studies.
| STUDY | No. of patients / lesions | IS /mortality rate | Topography, comments | Hemorrhage | T2 Intermediate with surrounding high signal | Target-like ADC | Contrast-enhancement | Vascular complications |
|---|---|---|---|---|---|---|---|---|
| 1/>20 | Y/100% | All areas including the brainstem but mostly seen at the CMJ. | Y | Y | 1 lesion | Y | N | |
| 11/ | Y/ | Multiple lesions predominant at the CMJ. One patient had nasosinusal involvement. | Y | 4p | N | |||
| 3/23 | Y/100% | All areas (19 supratentorial, 4 infratentorial). | Y | 52% lesions | 1p | N | ||
| 18/ | Y/89% | 12 patients with MRI. Lesions involving BNT (13p), CMJ (10p), corpus callosum (7p), brainstem (2p). | 8p | 7p | N | |||
| 6/36 | Y/100% | All areas but mostly seen at the CMJ. | 39% lesions | 42% lesions | N | |||
| 8/ | Y/75% | 6 Patients with | N | 2p | 1p | 6p | N | |
| 9/ | Y/89% | 4 patients with MRI. Two patients with nasosinusal involvement. | 1p | 4p | ICA (proximal) | |||
| 1/ | Y/100% | No MRI performed. Nasosinusal involvement. | ICA (fusiform, proximal) | |||||
| 1/ | Y/100% | Multiple lesions located in the right cerebral hemisphere. | N | |||||
| 1/ | N/0% | Multiple lesions located in the CMJ and WM. | Y | Y | N | |||
| 5/ | Y/100% | All areas. | N | Y | 2p | N | ||
| 1/0 | Y/0% | No parenchymal lesion. Nasosinusal involvement. | ACA (saccular, proximal) | |||||
| 1/ | Y/100% | All areas but mostly seen at the CMJ. | Y | Y | N | |||
| 1/1 | N/100% | Lesion located at the CMJ of cerebrum. | Y | Y | N | |||
| 1/ | Y/100% | No topographic description. | Y | Y | Y | N | ||
| 8/27 | Y (50%)/≥75% | 5 Patients with MRI. Lesions located in the CMJ, posterior fossa and BNT. One patient with meningitis. | 25% lesions | 55% lesions | N |
Abbreviations.—IS: Immunosuppression; NA: not available; p: patient; CMJ: corticomedullary junction; BNT: basal nuclei and thalami; WM: white matter; ICA: internal carotid artery; ACA: anterior cerebral artery
Characteristics of 21 patients with cerebral aspergillosis.
| #/age/sex | Risk factors | IS | Mycological positive findings | Pathogen | Degree of certainty | Other organs involved | MRI findings | Survival, follow-up |
|---|---|---|---|---|---|---|---|---|
| 1 /59/M | Sphenoidal sinusitis | No | Surgical debridement | Proven | Paranasal sinuses | Lateral sinus thrombophlebitis, aneurysms | Yes, 21 months | |
| 2 /73/M | Facial injury with osteosynthesis | No | Surgical resection and debridement | Proven | Paranasal sinuses | Abscess, subdural empyema | Yes, 4 years | |
| 3 /72/M | Ethmoidal sinusitis, multiple myeloma, steroids | Yes | Surgical resection | Proven | Paranasal sinuses, orbital cavity | Abscess | Yes, 14 months | |
| 4 /77/M | Ethmoidal sinusitis | No | Surgical resection | Proven | Paranasal sinuses | Aneurysm, abscesses, subdural empyema | Yes, 10 months | |
| 5 /55/F | Frontal sinusitis, lung Tx, T-cell suppressor, steroids | Yes | Surgical resection | Proven | Paranasal sinuses | Abscess | Yes, 5 years | |
| 6 /77/M | Facial injury with osteosynthesis | No | Surgical resection | Proven | Paranasal sinuses | Abscess | Yes, 23 months | |
| 7 /65/F | Frontal sinusitis, lymphoma in remission for 11 years | No | Surgical resection | Probable | Paranasal sinuses | Abscess | Yes, 12 months | |
| 8 /84/M | Sphenoidal sinusitis | No | Sinus biopsies | Proven | Paranasal sinuses, orbital cavity | Abscess, subdural empyema | Yes, 7 months | |
| 9 /74/M | Myeloid sarcoma, chemotherapy, neutropenia | Yes | Tracheal aspiration, GM (BAL, serum) | Proven | Lung | Abscess | No, 4 days | |
| 10 /64/M | Heart Tx, T-cell suppressor, steroids | Yes | GM (CSF, serum) | Probable | Lung | Abscesses | Yes, 5 years | |
| 11 /47/F | Crohn disease, steroids, acute liver failure | Yes | Sputum, tracheal aspiration, BAL, GM (BAL, serum) | Probable | Lung | Abscesses, aneurysm | No, 31 days | |
| 12 /35/M | Lung/liver Tx, T-cell suppressor, steroids, cystic fibrosis, diabetes mellitus | Yes | Sputum, tracheal aspiration, GM (serum), post-mortem biopsies (lung, trachea, bronchi, brain, heart, thyroid, liver, pancreas, small bowel) | Proven | Lung, trachea, bronchi, heart, thyroid, liver, pancreas, small bowel | Abscesses | No, 23 days | |
| 13 /44/M | Alcoholic liver failure, steroids, liver cirrhosis | Yes | Tracheal aspiration, post-mortem (thyroid, kidney, spleen, brain) | Proven | Lung, kidney, spleen | Abscesses, aneurysms | No, 20 days | |
| 14 /57/M | Lung Tx, T-cell suppressor, steroids | Yes | Tracheal aspiration, lung, skin, bronchus, post-mortem (kidney, heart, brain) | Proven | Lung, heart, skin | Abscesses | No, 11 months | |
| 15 /59/M | Glioblastoma, radio-chemotherapy | Yes | Post-mortem (lung, brain) | Proven | Lung | Abscesses | No, 83 days | |
| 16 /58/M | Heart Tx, T-cell suppressor, steroids | Yes | GM (CSF, BAL) | Probable | Lung | Abscesses | Yes, 3 years | |
| 17 /55/M | Liver Tx, T-cell suppressor, steroids | Yes | GM (CSF, BAL, serum) | Probable | Lung, heart | Abscesses, cerebral ischemia | Yes, 13 months | |
| 18 /53/M | Bladder neoplasm, chemotherapy, steroids | Yes | Sputum, GM (BAL) | Probable | Lung | Abscesses | No, 62 days | |
| 19 /49/M | AIDS | Yes | Post-mortem (brain) | Proven | - | Abscesses | No, 68 days | |
| 20 /58/F | End-stage kidney failure, hemodialysis, steroids | Yes | Tracheal aspiration, GM (serum), post-mortem (lung, heart, thyroid, lymph node, brain) | Proven | Lung, heart, thyroid, lymph node | Abscesses | No, 18 days | |
| 21 /58/M | Heart Tx, T-cell suppressor, steroids | Yes | Brain biopsy | Proven | - | Abscesses | No, 16 months |
Abbreviations.—BAL: bronchoalveolar lavage; GM: galactomannan; IS: immunosuppression; Tx: transplantation
Numbers and type of lesions on initial MRI for the eight patients with direct spread of infection.
| Topography | ||||||||
|---|---|---|---|---|---|---|---|---|
| #/age/sex | No. of non- vascular lesions | Invasive parenchymal lesion | Subdural empyema | Hemorrhage | T2 Intermediate with surrounding high signal | Target-like ADC | Contrast enhancement Annular/Nodular | Vascular complications |
| 0 | 0 | 0 | 0 | 0 | 0 | -/- | 3 | |
| 2 | 1 | 1 | 1 | 0 | 0 | 1/0 | 0 | |
| 2 | 1 | 1 | 0 | 0 | 0 | 1/0 | 0 | |
| 5 | 4 | 1 | 4 | 0 | 0 | 4/0 | 1 | |
| 1 | 1 | 0 | 1 | 0 | 1 | 1/0 | 0 | |
| 1 | 1 | 0 | 1 | 0 | 0 | 1/0 | 0 | |
| 1 | 1 | 0 | 1 | 0 | 1 | 1/0 | 0 | |
| 1 | 0 | 1 | 0 | 0 | 0 | 0/0 | 0 | |
Fig 1Multiplanar reconstruction of a frontal cerebral abscess with a frontal sinus starting point (patient #5) explored with gadolinium-enhanced T1W (A, B and C) and T2W (D).
These sequences show a large frontal edema and a polylobulated abscess with a necrotic center and a peripheral annular enhancement.
Numbers and type of lesions on initial MRI for the 13 patients with hematogenous dissemination.
| Topography | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #/age/sex | No. of non-vascular lesions | CMJ | BNT | CC | WM | BS | Subtentorial | Hemorrhage | T2 Intermediate with surrounding high signal | Target-like ADC | Contrast enhancement Annular/Nodular | Vascular complications |
| 18 | 11 | 4 | 1 | 0 | 0 | 2 | 3 | 0 | 0 | 0/0 | 0 | |
| 67 | 50 | 2 | 1 | 11 | 0 | 3 | 2 | 13 | 1 | 13/53 | 0 | |
| 47 | 26 | 4 | 2 | 5 | 1 | 9 | 7 | 0 | 1 | 32/15 | 1 | |
| 23 | 9 | 3 | 2 | 9 | 0 | 0 | 2 | 0 | 0 | 0/0 | 0 | |
| 18 | 9 | 2 | 0 | 3 | 2 | 2 | 4 | 0 | 1 | 14/0 | 8 | |
| 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1/0 | 0 | |
| 44 | 33 | 1 | 1 | 4 | 1 | 4 | 6 | 0 | 0 | 0/0 | 0 | |
| 7 | 5 | 2 | 0 | 0 | 0 | 0 | 3 | 5 | 2 | 0/0 | 0 | |
| 6 | 5 | 0 | 1 | 0 | 0 | 0 | 3 | 0 | 1 | 2/4 | 0 | |
| 24 | 17 | 6 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 16/0 | 0 | |
| 6 | 5 | 1 | 0 | 0 | 0 | 0 | 4 | 4 | 6 | 6/0 | 0 | |
| 53 | 38 | 3 | 0 | 11 | 1 | 0 | 7 | 0 | 2 | 0 | ||
| 15 | 8 | 3 | 0 | 2 | 0 | 2 | 0 | 4 | 2 | 12/0 | 0 | |
| - | ||||||||||||
Abbreviations.—CMJ: corticomedullary junction; BNT: basal nuclei and thalamus; CC: corpus callosum; WM: white matter; BS: brainstem; NA: not available
Fig 2Left thalamic abscess with target-like characteristics (patient #10).
The DWI sequence (A) and the ADC cartography (B) show a central hypointense area on DWI (high ADC value), a hyperintense circular area on DWI (low ADC) and a peripheral milder hyperintensity (upper ADC value rim). (C) Annular peripheral enhancement after gadolinium injection on T1W images. (D) Mild hypointense rim on T2*W images.
Fig 3Aspergillosis abscess in the right thalamolenticular area due to hematogenous dissemination (patient #13).
(A) On gross examination, the lesion is non-hemorrhagic with central necrosis (arrow). (B) On T2*, the abscess is surrounded by a mild hypointense ring (arrow). (C) Gadolinium-enhanced T1W imaging shows mild annular enhancement. (D) ADC cartography shows a target-like lesion with a central high ADC value, a circular area with a low ADC value and a peripheral upper ADC value rim.
Characteristics of vascular complications.
| Topography | ||||
|---|---|---|---|---|
| #/age/sex | No. of aneurysms | Proximal | Distal | Characteristics |
| 2 | 2 | 0 | Thrombosis of lateral sinus | |
| Internal carotid artery / proximal / saccular | ||||
| Middle cerebral artery / proximal / saccular | ||||
| 1 | 1 | 0 | Anterior communicating artery / proximal / saccular | |
| 1 | 0 | 1 | Middle cerebral artery / distal / fusiform | |
| 8 | 3 | 5 | Superior cerebellar artery / proximal / fusiform | |
| Posterior cerebral artery / proximal / saccular | ||||
| Posterior cerebral artery / distal / fusiform | ||||
| Internal carotid artery / proximal / saccular | ||||
| Pericallosal artery / distal / fusiform | ||||
| Thalamic artery / distal / fusiform | ||||
| Middle cerebral artery / distal / fusiform | ||||
| Middle cerebral artery / distal / fusiform | ||||
Fig 4Macroscopic and imaging characteristics of vascular complications (patient #13).
Gross examination (A) and cerebral angiogram (B) show aneurysmal lesions on superior cerebellar artery, posterior cerebral artery (arrows) and a ruptured aneurysm of the distal part of the basilar artery (arrowhead). The 3D angiography (C) shows an additional distal fusiform aneurysm on the middle cerebral artery (arrowhead). Massive cerebral hemorrhage into the basal cisterns (interpedoncular and pontine cisterns) visualized on gross examination (D) and non-enhanced CT scan (E and F).
Fig 5Histological findings (patients #9, #12, #13).
(A) Hematoxylin-eosin stain (HE) (×20), destruction of a vessel with fibrinoid necrosis (arrows). (B) Grocott methenamine silver stain (GMS) (×40), vascular wall invaded by branching septate hyphae. (C) GMS (×4), intracerebral fungal aneurysm (dotted ellipse) with the interruption of the internal elastic lamina (arrows). (D) HE (×20), aneurysm wall containing hyphae, polynuclear cells (arrows) and giant cells (arrowheads).
Fig 6Histological abscess layers.
Periodic acid-Schiff stain (×20) shows distinct areas with (1) central necrosis, (2a) an intermediate dense hyphal rim, (2b) an external layer of granulation tissue and (3) edematous brain tissue. On MRI, annular enhancement after gadolinium and mild hypointense signal on T2*-weighted images correspond to layer 2a and 2b (see Fig 2C and 2D).
Fig 7Evolution of a left thalamic abscess (patient #10) from day 1 to month 30.
T1 after gadolinium injection, T2*, FLAIR and Diffusion-weighted images show annular peripheral enhancement with central necrosis and a progressive decrease in size starting at month 3.
Fig 8Hypointense signal T2*.
Comparison between a hemorrhagic lesion (marked central and peripheral hypointensity areas) (arrow) and a non-hemorrhagic abscess (mild annular hypointensity) (arrowhead) (patient #11).